Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, 02 1995, 567-570, Vol 39, No. 2
K Nagata, E Takagi, M Tsuda, T Nakazawa, H Satoh, M Nakao, H Okamura and T Tamura
The proton pump inhibitors omeprazole and lansoprazole and its acid-
activated derivative AG-2000, which are potent and specific inhibitors of
urease of Helicobacter pylori (K. Nagata, H. Satoh, T. Iwahi, T. Shimoyama,
and T. Tamura, Antimicrob. Agents Chemother. 37:769-774, 1993), inhibited
the growth of H. pylori. The growth was inhibited not only in
urease-positive clinical isolates but also in their urease- negative
derivatives which had no urease polypeptides. AG-1789, a derivative of
lansoprazole with no inhibitory activity against H. pylori urease, also
inhibited the growth of both strains even more strongly than the urease
inhibitors lansoprazole and AG-2000. Furthermore, the antibacterial
activity of omeprazole and lansoprazole was not affected by glutathione or
dithiothreitol, which completely abolished the inhibitory activity of
lansoprazole against H. pylori urease. These results indicated that the
inhibitory action of these compounds against the growth of H. pylori was
independent from the inhibitory action against urease.
Copyright © 1995 by the American Society for Microbiology. All rights reserved.
Inhibitory action of lansoprazole and its analogs against Helicobacter pylori: inhibition of growth is not related to inhibition of urease
Department of Bacteriology, Hyogo College of Medicine, Japan.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»